Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun;15(2):e40-e49.
doi: 10.1183/20734735.0165-2019.

Living well with severe asthma

Affiliations
Review

Living well with severe asthma

Michelle A Stubbs et al. Breathe (Sheff). 2019 Jun.

Abstract

Living well with severe asthma can be challenging. People with severe asthma can be refractory to treatment, can experience poor symptom control and are at a heightened risk of death. Patients experience symptoms of shortness of breath, chest tightness, cough and wheeze. These symptoms influence many aspects of an individual's life, resulting in emotional, financial, functional and medication-related burdens that negatively impact quality of life. Quality of life is known to be influenced by individual levels of satisfaction that stem from real-life treatment experiences. This experience is portrayed through the lens of the patient, which is commonly referred to as the patient perspective. The patient perspective is only one element of the patient experience. It influences health status, which, in severe asthma, is commonly assessed using validated health-related quality of life measures. A positive patient perspective may be achieved with implementation of management strategies tailored to individual needs. Management strategies developed in partnership between the patient, the severe asthma multidisciplinary team and the general practitioner may minimise disease-related impairment, allowing patients to live well with severe asthma.

Key points: Despite advances in treatment over the past decade, the experience of living with severe asthma has not significantly improved, with high levels of burden influencing the patient perspective.The impact of severe disease is not only restricted to asthma symptoms and acute attacks. It causes significant emotional, financial, functional and medication-related burdens, leading to impaired health-related quality of life.Clinical outcomes should not be stand-alone measures in severe asthma. Nonclinical measures should also be considered when evaluating health-related quality of life.Disease burden may be minimised and quality of life improved via self-management strategies, including education sessions, written asthma action plans, symptom monitoring, breathing exercises, physical activity and psychotherapeutic interventions.

Educational aims: To demonstrate the importance of the patient perspective in severe asthma.To identify the significant levels of disease burden associated with severe asthma.To discuss quality of life in severe asthma.To outline strategies that increase well-being in severe asthma.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: M.A. Stubbs has nothing to disclose. Conflict of interest: V.L. Clark receives a fellowship from the National Health and Medical Research Council, Centre of Research Excellence in Severe Asthma, and also reports a grant from AstraZeneca to cover research-related costs, received for providing education to AstraZeneca staff, outside the submitted work. Conflict of interest: V.M. McDonald reports grants and speaker fees from GlaxoSmithKline and AstraZeneca, and personal fees for educational symposia from Menarini, all outside the submitted work.

Figures

Figure 1
Figure 1
Symptoms, impacts, areas of burden and treatment options for people living with severe asthma.

Similar articles

Cited by

References

    1. Chung KF, Wenzel SE, Brozek JL, et al. . International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014; 43: 343–373. - PubMed
    1. Hekking PP, Wener RR, Amelink M, et al. . The prevalence of severe refractory asthma. J Allergy Clin Immunol 2015; 135: 896–902. - PubMed
    1. von Bülow A, Kriegbaum M, Backer V, et al. . The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract 2014; 2: 759–767. - PubMed
    1. Foster JM, McDonald VM, Guo M, et al. . “I have lost in every facet of my life”: the hidden burden of severe asthma. Eur Respir J 2017; 50: 1700765. - PubMed
    1. Hyland ME, Jones RC, Lanario JW, et al. . The construction and validation of the Severe Asthma Questionnaire. Eur Respir J 2018; 52: 1800618. - PMC - PubMed

LinkOut - more resources